Verona Pharma Inc. (VRNA) Cash Funds per Single Share

Verona Pharma Inc. - graphic logo of issuer VRNA

The growth of Verona Pharma plc (VRNA) is driven by the market launch of Ohtuvayre and the prospects of acquisition by industry behemoths. Cash per share confirms financial stability, where 5.07 is recorded as the baseline value. The company's advantage lies in its unique COPD therapy mechanism and strong pricing power. David Zaccardi's team is currently focusing on executing commercial plans while maintaining shareholder confidence.

Verona Pharma PLC (VRNA): Cash per Single Share from 07/04/2022 to 10/18/2025

Comprehensive metric breakdowns and analytics for Verona Pharma (VRNA)

- market price and analyst price targets:
- cash availability and cash flow indicators:
Summary company analysis:VRNA, Verona Pharma Inc.
Manufactured products of veronapharma.com

For long-term risk control, it is critical to monitor the liquid capital reserve, which per share amounts to 5.07. By analyzing the cash per share history, an investor assesses the ability of biopharmaceutical innovator Verona Pharma plc (VRNA) to fund the development of breakthrough inhalation drugs without incurring external debt, confirming the company's financial stability within the respiratory therapy segment.

Analysis of competing companies

Cash on Hand per Share Haleon Corp HLN|Cash per Single Share KVUE (Kenvue Health)|Jyong Biotech (MENS) - Cash Funds Volume per Share|Cash per Share LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Cash Funds per Share|PRGO - Cash Funds per Share|Alvotech Corp (ALVO) - Cash per Single Share|LQDA: Cash per Share|Cash on Hand per Share glpg.com (GLPG)|Cash Funds per Share ANI Pharmaceuticals Inc|MNKD: Amount of Cash per Share|Cash per Single Share AMPH (Amphastar)|PCRX - Cash on Hand per Share|Cash per Share SPRY (ars-pharma.com)|Amount of Cash per Share TBPH|Aquestive Therapeutics, Inc. - Cash per Share|scpharmaceuticals.com - Cash Calculated per Single Share|Tectonic (TECX) - Cash Funds per Share|Cash per Single Share Tonix Pharmaceuticals Inc.|Cash Funds per Share sxtchina.com|Cash per Single Share Eupraxia Pharmaceuticals (EPRX)|Cash per Share BHST|EXOZ - Cash on Hand per Share|Oramed - Cash per Single Share|Entera Bio Ltd. (ENTX) - Cash on Hand per Share|HYFT - Cash Funds per Share|ABVC: Cash Funds per Share|CPIX: Cash per Share|Quantum BioPharma Ltd. - Amount of Cash per Share|FGEN (FibroGen Corp) - Cash per Share|Telomir Pharma (TELO) - Cash Funds Calculated per Share|Cash Funds per Share Rani Therapeutics Inc (RANI)|SNYR (Synergy CHC Corp.) - Amount of Cash per Share|Cash Funds per Share Rallybio Corporation RLYB|LEXX: Cash Funds per Single Share|PULM - Cash Funds per Share|Amount of Cash per Share PTHL (Pheton Holdings)|Aptorum (APM) - Cash Funds per Share|LYRA (Lyra Therapeutics) - Cash Funds per Share|Cash Funds per Share Impact BioMedical Inc|TNF Pharmaceuticals - Cash Money per Share|Cash per Share YCBD|Cash per Share PainReform Ltd. (PRFX)|Cash Funds per Share Altamira Therapeutics Ltd CYTO|LIPO (lipella.com) - Cash Money per Share|OptiNose - Cash per Share|Cash Money per Share PIRS|PROC: Cash per Share|Petros - Amount of Cash per Share|Cash per Single Share QLI|SLRN: Amount of Cash per Share|Cash per Single Share TFFP (TFF Pharmaceuticals, Inc.)